Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Haese

Showing results (71-80 of 214) with videos related to

Pageof 22
Sort By:
BJU International|October 15, 2010
Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory studyThomas Steuber, Lars Budäus, Jochen Walz, et al.
The Prostate|August 16, 2022
New strategy for the identification of prostate cancer: The combination of Proclarix and the prostate health indexDaniela Terracciano, Evelina La Civita, Alcibiade Athanasiou, et al.
Clinical Chemistry|March 26, 2003
Standardization of two immunoassays for human glandular kallikrein 2Alexander Haese, Ville Vaisanen, Judith A Finlay, et al.
BJU International|August 14, 2012
Accuracy of HistoScanning™ for the prediction of a negative surgical margin in patients undergoing radical prostatectomyGeorg Salomon, Jan Spethmann, Ann Beckmann, et al.
BJU International|March 31, 2019
A comparative study of robot-assisted and open radical prostatectomy in 10 790 men treated by highly trained surgeons for both proceduresAlexander Haese, Sophie Knipper, Hendrik Isbarn, et al.
BJU International|October 17, 2013
Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm?Sami-Ramzi Leyh-Bannurah, Jens Hansen, Hendrik Isbarn, et al.
Oncology Letters|November 2, 2013
Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosisHüseyin Sirma, Margarethe Broemel, Laura Stumm, et al.
BJU International|February 26, 2015
Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteriaPhilipp Mandel, Thomas Steuber, Sascha Ahyai, et al.
BJU International|April 24, 2012
Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patientsLars Budäus, Hendrik Isbarn, Pierre Tennstedt, et al.
BJU International|January 20, 2011
Inverse stage migration in patients undergoing radical prostatectomy: results of 8916 European patients treated within the last decadeLars Budäus, Jan Spethmann, Hendrik Isbarn, et al.
Pageof 22

Showing results (71-80 of 214) with videos related to

Sort By:
Pageof 22
BJU International|October 15, 2010
Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory studyThomas Steuber, Lars Budäus, Jochen Walz, et al.
The Prostate|August 16, 2022
New strategy for the identification of prostate cancer: The combination of Proclarix and the prostate health indexDaniela Terracciano, Evelina La Civita, Alcibiade Athanasiou, et al.
Clinical Chemistry|March 26, 2003
Standardization of two immunoassays for human glandular kallikrein 2Alexander Haese, Ville Vaisanen, Judith A Finlay, et al.
BJU International|August 14, 2012
Accuracy of HistoScanning™ for the prediction of a negative surgical margin in patients undergoing radical prostatectomyGeorg Salomon, Jan Spethmann, Ann Beckmann, et al.
BJU International|March 31, 2019
A comparative study of robot-assisted and open radical prostatectomy in 10 790 men treated by highly trained surgeons for both proceduresAlexander Haese, Sophie Knipper, Hendrik Isbarn, et al.
BJU International|October 17, 2013
Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm?Sami-Ramzi Leyh-Bannurah, Jens Hansen, Hendrik Isbarn, et al.
Oncology Letters|November 2, 2013
Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosisHüseyin Sirma, Margarethe Broemel, Laura Stumm, et al.
BJU International|February 26, 2015
Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteriaPhilipp Mandel, Thomas Steuber, Sascha Ahyai, et al.
BJU International|April 24, 2012
Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patientsLars Budäus, Hendrik Isbarn, Pierre Tennstedt, et al.
BJU International|January 20, 2011
Inverse stage migration in patients undergoing radical prostatectomy: results of 8916 European patients treated within the last decadeLars Budäus, Jan Spethmann, Hendrik Isbarn, et al.
Pageof 22